Fenton S, Sherrard DJ (1995) Fisk factors for renal osteodystrohpy: a multivariant analysis. J Bone Miner Res 10: 149-156 8. Goodman WG, Coburn JW, Ramirez JA, Slatopolsky E, Salusky IB (1993) Renal osteodystrophy in adult and pediatric patients. In: Favus M (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism. Raven, New York, pp 304-323 9. Salusky IB, Coburn JW, Foley J, Nelson P, Fine RN (1986) Effects of oral calcium carbonate on control of serum phosphorus and changes in plasma aluminum levels after discontinuation of aluminum-containing gels in children receiving dialysis. J Pediatr 108:767-770 10. Salusky IB, Foley J, Nelson P, Goodman WG (1991) Aluminum accumulation during treatment with aluminum hydroxide and dialysis in children and young adults with chronic renal disease. N Engl J Med 324:527-531 11. Goodman WG, Salusky IB (1991) Evolution of secondary hyperparathyroidism during daily oral calcitriol therapy in pediatric renal osteodystrophy. Contrib Nephrol 90: 189-195 12. Slatopolsky E, Weerts C, Thielan J, Horst RL, Harter H, Martin KJ (1984) Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxycholecalciferol in uremic patients. J Clin Invest 74:2136-2143 13. Delmez JA, Dougan CS, Gearing BK, Rothstein M, Windus DW, Rapp N, Slatopolsky E (1987) The effects of intraperitoneal cal653